Breadcrumb

null Amine Benmassaoud, MD

Investigator, RI-MUHC, Glen site

Cardiovascular Health Across the Lifespan Program

Assistant Professor, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University

Department of Medicine, Division of Gastroenterology and Hepatology, MUHC

 

Keywords

endohepatology • portal hypertension • liver cirrhosis • sarcopenia • frailty • liver transplantation

Research Focus

My research focuses on the development and validation of new approaches that can improve the diagnosis, staging, and monitoring of portal hypertension and vascular liver diseases by conducting high quality clinical trials. Liver diseases are extremely common affecting 1 in 4 Canadian. Once advanced liver disease develops, portal hypertension becomes the main driver of severe complications and death. I am interested in evaluating both invasive and non-invasive diagnostic tools. I will also address critical issues rooted in whole-person care, such as malnutrition, sarcopenia, and frailty. These issues are well-known to be common in patients with advanced liver disease and are associated with worse outcomes.

Selected Publications

Click on Pubmed to see my current publications list

  • Wang TJ, Chang K, Rubin RA, …, Benmassaoud A, et al. International Expert Delphi Consensus on EUS Guided Portosystemic Pressure Gradient: Best Practices and Future Directions. Clin Gastroenterol Hepatol. 2025 Dec 16. Epub ahead of print. PMID: 41412540.

  • Benmassaoud A, Bessissow A, Samoukovic G, et al. EUS-Guided Liver Biopsy and Portal Pressure Measurement Compared With a Transjugular Approach: A Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2025 Oct 3. Epub ahead of print. PMID: 41046961.

  • Xie XY, Benmassaoud A. Advances in the diagnosis and management of clinically significant portal hypertension in cirrhosis: A narrative review. World J Hepatol. 2025 Jun 27. PMID: 40606915.

  • Benmassaoud A, Gillis C, Geraci O, et al. Prehabilitation in patients with cirrhosis awaiting liver transplantation: protocol of a feasibility study. BMJ Open. 2024 Jun 25;14(6):e081362. PMID: 38925705.

  • Benmassaoud A, Roccarina D, Arico F, et al. Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites. Am J Gastroenterol. 2020 Dec;115(12):2074-2077. PMID: 33156111.